Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo. Taking two Mounjaro shots at the same time (or injecting double the dose to make up for a missed one) is not recommended and is not safe. Each KwikPen delivers a fixed weekly dose; the prescribing schedule exists for a clinical reason, not as a rough guide. Mounjaro is a prescription-only medicine, and every dosing decision belongs with your prescriber, not to improvisation on a Sunday evening when you realise you forgot Thursday's injection.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Friday morning, the week has been chaotic, and you're almost certain your last injection was last Sunday but you're not entirely sure. The instinct to take two pens' worth to compensate is understandable. It is also the wrong call.
Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist. It slows gastric emptying, dampens appetite signals and influences blood-sugar regulation, effects that are carefully titrated across weeks to give your body time to adjust. Doubling a dose floods those pathways simultaneously. The result is not twice the benefit; it is a steep increase in gastrointestinal side effects: intense nausea, vomiting, diarrhoea and abdominal pain are all considerably more likely. For a small number of people, a sudden high dose can also trigger dizziness and dehydration severe enough to need medical attention.
The NHS tirzepatide guidance is clear on the missed-dose rule: if fewer than four days remain before your next scheduled injection, skip the missed one and continue as normal. If more than four days have passed, inject as soon as you remember and then resume your regular weekly day. Those are the two scenarios. There is no third option involving a double dose.
If you are genuinely uncertain which scenario applies to you, or if your pen has been damaged, stored incorrectly or behaved strangely during injection, contact your prescriber before doing anything. That is exactly what our support team is here for, seven days a week.
Mounjaro treatment starts at 2.5 mg. That is not a token gesture before the real treatment begins, it is a deliberate period of physiological adjustment. The prescriber steps the dose upward, typically every four weeks, to let your body's tolerance build. Taking two shots in one week does not move you onto the next rung of that ladder. It just gives you a larger hit of a dose your system has not been prepared for.
This matters for safety beyond the immediate side-effect risk. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded a roughly 20–21% average weight reduction over 72 weeks at the 15 mg maintenance dose, results achieved by following the prescribed titration schedule, not by compressing it. Shortcuts do not replicate that outcome. They largely just replicate the nausea.
There is also a practical pharmacy point worth knowing. Each Mounjaro KwikPen contains four pre-set doses. Taking two pens' worth of 2.5 mg is not the same thing as moving to 5 mg, the pen itself is calibrated to the licensed strength. Tirzepatide is available in six UK strengths from 2.5 mg to 15 mg, and each strength is a separate device. If you feel the current dose is no longer working, that conversation belongs in a clinical review, not in a second injection.
Questions about whether your dose increase is due, or whether a treatment review makes sense, are ones our clinical team handles routinely.
There are a few situations where the thought of a second injection seems logical, even if it is not medically appropriate. It helps to name them.
Thinking a higher dose will speed weight loss. Dose increases are paced to protect tolerability, not to slow results. Pushing ahead on your own schedule almost always produces more side effects and no meaningful improvement in outcomes. If you genuinely believe a dose change is overdue, the answer is a conversation with your prescriber, not a second pen.
For context on what treatment costs at each stage, the Mounjaro price page explains how pricing works by dose, worth reading before assuming two pens is an economical workaround.
Suspecting the injection did not go in properly. If you are uncertain whether your dose delivered (the pen clicked but you are not sure) do not re-inject. Our guidance on Mounjaro shots explains what a successful injection looks and feels like, which can help you decide whether to call your prescriber or pharmacist. A second dose in that scenario is the same risk as a deliberate double dose.
Wanting to skip ahead to a higher maintenance dose faster. This is understandable, but the titration exists for a reason backed by the SmPC and endorsed by the prescriber reviewing your treatment. If you are struggling with the pace, raise it. Our prescribers hear this question often, and there is a clinical conversation to be had, just not one that ends with two injections in a week. For more on how the injection process works at each stage of treatment, the page covering tirzepatide shots walks through the practicalities in detail.
For a broader look at timing, injection-day logistics and what to do if your routine shifts, the guidance on when to take your Mounjaro shot covers the practical detail in full.
If you have already injected twice in one week, monitor how you feel closely. Mild nausea and stomach discomfort are likely; manage them with small frequent meals, staying well hydrated and resting as needed. If symptoms are severe (persistent vomiting, severe abdominal pain, signs of dehydration or anything that worries you) seek medical attention and tell the clinician what you have taken. Severe, persistent stomach pain that radiates to the back, with or without vomiting, warrants urgent assessment given the MHRA's guidance linking GLP-1 medicines to acute pancreatitis in rare cases.
Going forward, the most practical thing is to fix a consistent injection day and a simple reminder. A lot of missed doses happen on weeks where the usual routine breaks down. Some people find tying the injection to the same ritual each week helps, before the weekly food shop, or the same evening the bins go out. The specific day does not matter; the consistency does.
If you have further questions about your treatment, the Mounjaro FAQs cover common concerns, and our team is available seven days a week. If you are not yet on treatment and want to understand whether a clinical consultation is the right next step, our prescribers are ready to review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.